PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)
Published September 5, 2012 · Recall initiated: August 2, 2012
Summary
FDA records medical device Class III recall Z-2285-2012, published September 5, 2012 and initiated August 2, 2012. Recalling firm: Phadia US Inc; Status: Terminated; Reported quantity: 837 kits (96 assays per kit), total of 80,352 individual assays; Lot: Article Number 15696 Lot number #0067. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Phadia US Inc
- Distributor
- USA Nationwide.
- Lot
- Article Number 15696 Lot number #0067
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPhadia 1000 Instrument, Article Number 12-3800-01.January 24, 2018
- FDAQKC1692E The QKC1692E Quick Connect device connects endoscopes to the sterilization tray for C1220E liquidSeptember 5, 2012
- FDAProduct is labeled in part: "***MEDLINE***Extended PTFE Needle 6.5" (16.51cm) Length***Reorder:September 5, 2012
- FDASiemens Stratus(R) CS Acute Care(TM) D-dimer Calibrator (DDM CalPak) lots 502058002 and 501318002 TheSeptember 5, 2012
- FDAProduct is labeled in part: "***MEDLINE***Extended PTFE Coated Needle 4.0" (10.16cm) Length***Reorder:September 5, 2012
- FDAWhole Body X--ray Scanner This device is indicated as a whole body volume CT system. The system producesSeptember 5, 2012
Questions about this recall
Was PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies) recalled?
Yes. FDA published recall Z-2285-2012 on September 5, 2012. Reported hazard: Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter